NDC 70594-081-01 - Ampicillin and Sulbactam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-081
- Requested NDC
- 70594-081-01
- Package NDCs from labels
- 70594-081-01, 70594-081-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC | Astral SteriTech Private Limited
- Effective date
- 2024-12-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AMPICILLIN - Xellia Pharmaceuticals USA LLC | Astral SteriTech Private Limited | Xellia Pharmaceuticals USA LLC | Astral SteriTech Private Limited | 2024-12-10 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70594-081-02 | 2024-12-10 | C162847 | 48780-1 | 1030e365-55da-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
| 70594-081-02 | 2024-07-30 | C162847 | 48780-1 | 1030e365-55da-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
| 70594-081-02 | 2024-01-30 | C162847 | 48780-1 | 1030e365-55da-111a-e063-dadaa90a10e2 | Ampicillin and Sulbactam for Injection, USP (For Intramuscular or Intravenous Use) |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-081-01 | EA - Each | 70594-081 | fa63f778-cdd1-4bff-95ab-1aa4cb2493bc | 1 | 2021-11-09 |
| 70594-081-02 | EA - Each | 70594-081 | b91134d5-bf89-44aa-82da-b98cef6e7b86 | 1 | 2021-11-09 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| AMPICILLIN | AMPICILLIN SODIUM | Henry Schein, Inc. | 78988f6a-a73b-4d3b-9a76-d61a748c3c16 | 2026-07-31 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin Sodium | AMPICILLIN SODIUM | Sagent Pharmaceuticals | 5b3796dd-6f81-4999-ae2b-a13a72795729 | 2026-07-27 | Warnings, Adverse reactions | JFN36L5S8K |
| ampicillin | AMPICILLIN | Sagent Pharmaceuticals | 9d2aebe8-4f04-49dd-b1e5-80b962868dc3 | 2026-07-27 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 139b4b2e-46f7-44a8-9cc1-774afa463b80 | 2026-07-23 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | 006f9a3f-b4e3-4aa5-ac65-6cc3d3e2582d | 2026-07-22 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| ampicillin and sulbactam | AMPICILLIN AND SULBACTAM | Sagent Pharmaceuticals | a67ae347-487d-4751-a841-b321e81db26f | 2026-07-21 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| UNASYN | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Roerig | 155c7ec0-5862-404f-b1d0-f278f8a8bbda | 2026-07-10 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| UNASYN | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Roerig | 12eeb72a-403d-41be-bae4-4cb930862884 | 2026-07-09 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 72a37674-8cb2-4b40-aac8-d345ffcf22f2 | 2026-06-23 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 9a722de6-9dc0-4fb9-b63a-225385aa3314 | 2026-06-23 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | WG Critical Care, LLC | 77158167-0c1e-4f01-a5b0-a3df8ad121f5 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN | WG Critical Care, LLC | 12b6ac82-ca74-4f88-99ea-ae4a1c419b70 | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN | WG Critical Care, LLC | 38ec7b7a-9caf-45f2-88a1-0f78f089a1e4 | 2026-06-22 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin | AMPICILLIN SODIUM | NorthStar Rx, LLC | 3b683547-48ac-48ca-8fd4-6866fd17be34 | 2026-06-15 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Meitheal Pharmaceuticals Inc. | e6cf14a8-3ed9-4a7a-ba69-be0b794cbdc4 | 2026-06-10 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin | AMPICILLIN | ONESOURCE SPECIALTY PHARMA LIMITED | 519f3ba6-606f-bfc4-e063-6294a90af884 | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | JFN36L5S8K |
| AMPICILLIN | AMPICILLIN SODIUM | Henry Schein, Inc. | 06ca924c-5f3a-4924-90f4-5ba623daaa0e | 2026-04-30 | Warnings, Adverse reactions | JFN36L5S8K |
| Ampicillin and Sulbactam | AMPICILLIN SODIUM AND SULBACTAM SODIUM | Medical Purchasing Solutions, LLC. | 4e81c215-2ab6-87c6-e063-6294a90ac28c | 2026-04-02 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Hikma Pharmaceuticals USA Inc. | a65a70bf-4283-4bc0-b576-00c9ab29bd64 | 2026-03-25 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
| Ampicillin and Sulbactam | AMPICILLIN AND SULBACTAM | Hikma Pharmaceuticals USA Inc. | d3026cc0-95d8-44cf-be47-b5ebb8fd4568 | 2026-03-25 | Warnings, Adverse reactions | JFN36L5S8K DKQ4T82YE6 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.